When patients use both treatments concurrently, several precautions are warranted : Injection site management : Rotate sites systematically and avoid administering both injections in the same anatomical area on the same day Gastrointestinal monitoring : Tirzepatide's GI effects may be misattributed to lipotropic injections, potentially leading to inappropriate dose adjustments Hydration emphasis : Ensure adequate fluid intake given tirzepatide's potential to cause dehydration through GI effects Medication adjustments : Consider reducing doses of insulin or sulfonylureas when initiating tirzepatide to mitigate hypoglycemia risk Realistic expectations : Counsel patients that weight loss benefits derive primarily from tirzepatide's pharmacological action Cost considerations : Lipotropic injections represent additional out-of-pocket expense without proven incremental benefit Patients should seek immediate medical attention for severe or persistent abdominal pain (possible pancreatitis), right upper quadrant pain with fever or jaundice (gallbladder disease), signs of allergic reaction, persistent vomiting leading to dehydration, or symptomatic hypoglycemia if on insulin/sulfonylureas

Drawing 12.5 units for a 2.5mg starting dose requires careful technique
It also increases the production of cortisol, which serves as a precursor to endogenous progesterone and testosterone synthesis
It can be taken with or without food
Wolf J, Seto T, Han J-Y, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, et al
While receiving an IV drip that provides NAD+, you can also get an intramuscular shot of vitamin B12, or you could have the nutrients added to the IV bag